Come up with a name for your new list and we'll add to it:
iPierian raised a round of funding on May 18, 2010. Investors include
California Institute of Regenerative Medicine.
iPierian is a biotechnology company developing therapies for neurodegenerative disease, specifically focused on discovering monoclonal antibodies against targets of the Tau protein for treatment of Al…